Former Chinese drug regulator faces charges of taking kickbacks for approvals
Pharma Compliance Alert, April 11, 2007
A former Chinese drug regulator is about to go on trial on charges that he took kickbacks from drug makers in exchange for drug approvals. Zheng Xiaoyu was China's director of the State Food and Drug Administration until he was removed from his post in late 2005 in light of the allegations, reports several U.S. and Chinese news outlets.
According to the reports, Zheng took cash, a car, and other gifts from drug makers, including the Hainan Kangliyuan Group, which is accused of giving Zheng bribes in exchange for approvals of 277 drugs.
One of the drugs Zheng allegedly approved for bribes was an antibiotic responsible for at least 10 deaths before it was removed from the market, reports Business Week.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched